June 1, 2017
Vitrosorb are now in the final phase of getting the CE-marking for the SECORIM ABO columns A100, B100 and AB100.
Vitrosorb AB is a Swedish medical device company.
Vitrosorb AB develop, produce and market immunadsorption columns aimed to eliminate the blood group barrier of organ transplantation. Vitrosorb’s main product SECORIM©-ABO, facilitates ABO-incompatible transplantations through reduction of blood group A or B antibodies. By eliminating the blood group barrier for organ transplantation, the number of transplantations is estimated to increase by 30 to 40 percent.
SECORIM©-ABO facilitates ABO-incompatible transplantations through reduction of blood group A or B antibodies. SECORIM©-ABO enables transplantations across blood group barriers by specific removal the organ recipient’s blood group antigens.